GH1 and glioblastoma: In‐line with the tumour‐promoting role of GHR demonstrated in this study using several GBM models, targeted inhibition of GHR signalling using the prototypic GH antagonist GH‐G120K impaired GBM cell migration in vitro and decreased cell viability in PDCLsGHR high only.